Skip to main content

10 Result(s)

within A Czibere Remove this filter

and

  1. No Access

    Article

    Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

    T Schroeder, J Fröbel, R-P Cadeddu, A Czibere, A Dienst, U Platzbecker, G Bug… in Leukemia (2013)

  2. No Access

    Article

    Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

    The combination of azacitidine and donor lymphocyte infusions (DLI) as first salvage therapy for relapse after allogeneic transplantation (allo-HSCT) was studied in 30 patients with acute myeloid leukemia (AML; n

    T Schroeder, A Czibere, U Platzbecker, G Bug, L Uharek, T Luft, A Giagounidis… in Leukemia (2013)

  3. No Access

    Article

    Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases

    In the current study, we evaluated a combination of tacrolimus and mycophenolate mofetil (MMF) as GvHD prophylaxis in 50 patients undergoing truly nonmyeloablative (NM; 90 mg/m2 fludarabine, 2 Gy TBI) hematopoiet...

    F Zohren, T Schroeder, A Czibere, R Fenk, I Bruns… in Bone Marrow Transplantation (2011)

  4. No Access

    Article

    The Mexican Way: a feasible approach to avoid DMSO toxicity

    T Schroeder, R Fenk, C Saure, A Czibere, I Bruns, F Zohren… in Bone Marrow Transplantation (2011)

  5. No Access

    Article

    5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

    Patients with AML or myelodysplastic syndrome who relapse after allo-SCT have a poor prognosis. In the search for novel treatment strategies for these patients, we conducted a multicenter retrospective analysi...

    A Czibere, I Bruns, N Kröger, U Platzbecker, J Lind… in Bone Marrow Transplantation (2010)

  6. Article

    Bendamustine in patients with relapsed or refractory multiple myeloma

    In patients with multiple myeloma, bendamustine monotherapy is effective as 1st and 2nd line therapy. However, data for patients with advanced multiple myeloma is rare.

    M Michael, I Bruns, E Bölke, F Zohren, A Czibere… in European Journal of Medical Research (2010)

    Download PDF (1203 KB) View Article

  7. No Access

    Article

    Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia

    In this prospective study, we examined the toxicity and efficacy of an intensified conditioning regimen for treatment of patients with relapsed or high-risk acute lymphoblastic leukemia who undergo allogeneic ...

    F Zohren, A Czibere, I Bruns, R Fenk, T Schroeder, T Gräf… in Bone Marrow Transplantation (2009)

  8. No Access

    Article

    Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy

    D Bruennert, A Czibere, I Bruns, R Kronenwett, N Gattermann, R Haas, F Neumann in Leukemia (2009)

  9. No Access

    Article

    Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT

    To date, G-CSF is the most favoured cytokine administered for PBSC mobilization because of its great efficacy and lack of serious toxicity. Recently, a pegylated filgrastim (pegfilgrastim) has been introduced....

    G Kobbe, I Bruns, R Fenk, A Czibere, R Haas in Bone Marrow Transplantation (2009)

  10. No Access

    Article

    The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence

    We found that composition of cell subsets within the CD34+ cell population is markedly altered in chronic phase (CP) chronic myeloid leukemia (CML). Specifically, proportions and absolute cell counts of common...

    I Bruns, A Czibere, J C Fischer, F Roels, R-P Cadeddu, S Buest, D Bruennert… in Leukemia (2009)